ResMed develops, manufactures, distributes, and markets medical devices and cloud-based software solutions that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates through two segments, Sleep and Respiratory Care, and Software as a Service (SaaS).
Considering that respiratory is currently a MASSIVE issue, I believe there is a lot of LONG-TERM benefit to be taken from this. UNFORTUNATELY, it will be on the back of individuals who are currently coming off the ICU respirators related to COVID. Definitely a long-term play, as well as good for some nice quick pops (lows 3.16 $116; highs 2/10 $176)
I am loving this thing for its beautiful , and the fact that currently the company is performing very well relative to S&P and DOW.
Look for previous resistance at 173 and 176 for breakouts.